Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression

INTRODUCTION: Interstitial lung disease in rheumatoid arthritis (RA-ILD) is an extra-articular involvement that impairs the prognosis and for which there is still no well-coded treatment. The aim of this study was to evaluate abatacept (ABA) effectiveness and safety in patients with RA-ILD. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Tardella, Marika, Di Carlo, Marco, Carotti, Marina, Giovagnoni, Andrea, Salaffi, Fausto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599404/
https://www.ncbi.nlm.nih.gov/pubmed/34313866
http://dx.doi.org/10.1007/s10067-021-05854-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599404/
https://www.ncbi.nlm.nih.gov/pubmed/34313866
http://dx.doi.org/10.1007/s10067-021-05854-w

Ejemplares similares